// App-Quantinova.ai

302 : Highly elevated ferritin levels are associated with haemophagocytic lymphohistiocytosis/macrophage activation syndrome: are we missing treatable diagnoses? A retrospective service evaluation of diagnosis in patients with ferritin >10,000 microgram/L

Researchers

Presenter

  • Ethan S Sen

Principal Investigators

  • Louise Moran

  • Beverley Almeida

  • Rosie Close

  • Ema-Louise Long

  • Joshua Bennett

  • Catriona M Anderson

  • Kirsty McLellan

  • Samundeeswari Deepak

  • Kathy Gallagher

  • Peter Bale

  • Kamran Mahmood

  • Clare Pain

  • Flora McErlane

  • Rachel S Tattersall

Medical Centers

  • Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, UNITED KINGDOM

  • Translational Health Sciences, University of Bristol, Bristol

  • Department of Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool, UNITED KINGDOM

  • Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UNITED KINGDOM

  • University College London Great Ormond Street Institute for Child Health, University College London, London, UNITED KINGDOM

  • Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK

  • Paediatric Rheumatology, Great North Children's Hospital, Newcastle upon Tyne, UNITED KINGDOM

  • Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, UNITED KINGDOM

  • Paediatric Rheumatology, Birmingham’s Children’s Hospital, Birmingham, UNITED KINGDOM

  • Paediatrics, Addenbrookes Hospital, Cambridge, UNITED KINGDOM

  • Paediatric Rheumatology, Great North Children's Hospital, Newcastle upon Tyne, UNITED KINGDOM

  • Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UNITED KINGDOM

  • Department of Adult and Adolescent Rheumatology, Royal Hallamshire Hospital, Sheffield, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Hemophagocytic lymphohistiocytosis

  • Macrophage activation syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Interleukin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A